The place of gliclazide MB in modern treatment strategies for patients with type 2 diabetes mellitus
Sulfonylurea (SU) are an effective class of oral hypoglycemic drugs that have been used in clinical practice for more than 70 years. Despite the common mechanism of action, members of the class have significant intraclass differences in hypoglycemic activity, safety, and the presence of extrapancrea...
Saved in:
| Main Authors: | N. A. Petunina, N. S. Martirosian, E. V. Goncharova, M. E. Telnova, I. A. Kuzina, A. O. Shchetinina, E. A. Elmurzaeva |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2024-09-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/13184 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current data on the effectiveness of gliclazide and molecular mechanisms of action of the drug
by: Nina A. Petunina, et al.
Published: (2020-12-01) -
Results of the ADVANCE trial and interventional observational program ADVANCE-ON: whether our understanding of the relationship of glycemic factors and the risk of vascular complications in patients with type 2 diabetes has changed?
by: Marina Vladimirovna Shestakova, et al.
Published: (2015-12-01) -
Indonesia DIA-RAMADAN Study: A Real-life, Prospective and Observational of Gliclazide MR in Type-2 Diabetes Patients During Ramadan Fasting
by: Soebagijo Adi Soelistijo, et al.
Published: (2022-04-01) -
A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study)
by: Yury Shavkatovich Khalimov, et al.
Published: (2011-06-01) -
ANGIOTENSIN II RECEPTOR ANTAGONISTS AND NEPHROPROTECTION: PLACE OF OLMESARTAN
by: V. V. Fomin
Published: (2013-08-01)